Zablocki; Jeffery A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zablocki; Jeffery A..The latest application filed is for "bicyclic pyrazole bruton's tyrosine kinase inhibitors".

Company Profile

0.13.6

Zablocki; Jeffery A. - Los Altos CA
Zablocki, Jeffery A. - Mountain View CA
Zablocki, Jeffery A. - Lafayette CO
Zablocki; Jeffery A. - Skokie IL
Zablocki; Jeffery A. - Mt. Prospect IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclic Pyrazole Bruton's Tyrosine Kinase Inhibitors App 20220213092 - DeGoey; David A. ; et al.	2022-07-07
Purine inhibitors of cyclin dependent kinase 2 and IkappaB-alpha App 20050080261 - Lum, Robert T. ; et al.	2005-04-14
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity App 20040220231 - Lee, Len F. ; et al.	2004-11-04
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity Grant 6,794,396 - Lee , et al. September 21, 2	2004-09-21
Purine inhibitors of cyclin dependent kinase 2 & IKBA Grant 6,790,958 - Lum , et al. September 14, 2	2004-09-14
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity App 20040038939 - Lee, Len F. ; et al.	2004-02-26
Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents Grant 6,605,634 - Zablocki , et al. August 12, 2	2003-08-12
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity Grant 6,605,624 - Lee , et al. August 12, 2	2003-08-12
Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents App 20030096819 - Zablocki, Jeffery A. ; et al.	2003-05-22
Substituted pyridone compounds and methods of use App 20030073704 - Spohr, Ulrike D. ; et al.	2003-04-17
Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents Grant 6,440,973 - Zablocki , et al. August 27, 2	2002-08-27
Substituted pyrimidinone and pyridone compounds and methods of use Grant 6,420,385 - Spohr , et al. July 16, 2	2002-07-16
Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents Grant 6,180,643 - Zablocki , et al. January 30, 2	2001-01-30
Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors Grant 5,703,125 - Bovy , et al. December 30, 1	1997-12-30
Phenyl amidines derivatives useful as platelet aggregation inhibitors Grant 5,481,021 - Garland , et al. January 2, 1	1996-01-02
Peptide mimics useful as platelet aggregation inhibitors Grant 5,453,440 - Bovy , et al. September 26, 1	1995-09-26
Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors Grant 5,344,957 - Bovy , et al. September 6, 1	1994-09-06
Substituted heterocyclic derivatives useful as platelet aggregation inhibitors Grant 5,254,573 - Bovy , et al. October 19, 1	1993-10-19
Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof Grant 5,239,113 - Bovy , et al. August 24, 1	1993-08-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.